Cryo Cell International (CCEL) Shares Outstanding (Weighted Average) (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $8.1 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) changed 0.33% year-over-year to $8.1 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $8.1 million (changed 0.33% YoY) and the FY2025 annual result came in at $8.1 million, down 0.76% from the prior year.
• Shares Outstanding (Weighted Average) steadied at $8.1 million in Q1 2026 per CCEL's latest filing, from $8.1 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $8.5 million in Q1 2022 and bottomed at $8.1 million in Q1 2026.
• The 5-year median for Shares Outstanding (Weighted Average) is $8.3 million (2024), against an average of $8.3 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) rose 12.63%; it then slipped 2.71% in 2024.
• Tracing CCEL's Shares Outstanding (Weighted Average) over 5 years: stood at $8.5 million in 2022, then fell by 1.47% to $8.3 million in 2023, then retreated by 2.52% to $8.1 million in 2024, then declined by 0.76% to $8.1 million in 2025, then decreased by 0.17% to $8.1 million in 2026.
• Per Business Quant, the three latest CCEL Shares Outstanding (Weighted Average) figures stand at $8.1 million (Q1 2026), $8.1 million (Q4 2025), and $8.1 million (Q3 2025).

Peer Comparison